Enasidenib-Induced Differentiation Syndrome in IDH2-Mutant Acute Myeloid Leukemia

被引：5
|
作者：
Patel, Shyam A. [1 ,2 ]
机构：
[1] Stanford Univ, Dept Med, Div Hematol, Stanford Canc Inst,Sch Med, Stanford, CA 94305 USA
[2] Stanford Univ, Dept Med, Div Oncol, Stanford Canc Inst,Sch Med, Stanford, CA 94305 USA
来源：
JAMA ONCOLOGY | 2018年 / 4卷 / 08期
关键词：
MUTATIONS;
D O I：
10.1001/jamaoncol.2017.4724
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1110 / +
页数：3
相关论文
共 50 条
  • [1] Enasidenib-induced differentiation promotes sensitivity to venetoclax in IDH2-mutated acute myeloid leukemia
    Cathelin, Severine
    Sharon, David
    Subedi, Amit
    Cojocari, Dan
    Phillips, Darren C.
    Leverson, Joel D.
    MacBeth, Kyle J.
    Nicolay, Brandon
    Narayanaswamy, Rohini
    Ronseaux, Sebastien
    Liu, Guowen
    Chan, Steven M.
    LEUKEMIA, 2022, 36 (03) : 869 - 872
  • [2] Enasidenib-induced differentiation promotes sensitivity to venetoclax in IDH2-mutated acute myeloid leukemia
    Severine Cathelin
    David Sharon
    Amit Subedi
    Dan Cojocari
    Darren C. Phillips
    Joel D. Leverson
    Kyle J. MacBeth
    Brandon Nicolay
    Rohini Narayanaswamy
    Sebastien Ronseaux
    Guowen Liu
    Steven M. Chan
    Leukemia, 2022, 36 : 869 - 872
  • [3] CARDIAC TEMPONADE SECONDARY TO ENASIDENIB-INDUCED DIFFERENTIATION SYNDROME IN A PATIENT WITH ACUTE MYELOID LEUKEMIA
    Shah, Syed Yousaf
    Janagam, Pragna
    Thomas, Akesh
    Hussain, Raza
    CHEST, 2021, 160 (04) : 911A - 911A
  • [4] All-Trans Retinoic Acid Synergizes with Enasidenib to Induce Differentiation of IDH2-Mutant Acute Myeloid Leukemia Cells
    Kim, Yundeok
    Jeung, Hoi-Kyung
    Cheong, June-Won
    Song, Jaewoo
    Bae, Soo Han
    Lee, Jong In
    Min, Yoo Hong
    YONSEI MEDICAL JOURNAL, 2020, 61 (09) : 762 - 773
  • [5] Enasidenib-induced Sweet syndrome with differentiation syndrome
    Mohamed, Amr
    CLINICAL CASE REPORTS, 2021, 9 (05):
  • [6] Enasidenib in mutant IDH2 relapsed or refractory acute myeloid leukemia
    Stein, Eytan M.
    DiNardo, Courtney D.
    Pollyea, Daniel A.
    Fathi, Amir T.
    Roboz, Gail J.
    Altman, Jessica K.
    Stone, Richard M.
    DeAngelo, Daniel J.
    Levine, Ross L.
    Flinn, Ian W.
    Kantarjian, Hagop M.
    Collins, Robert
    Patel, Manish R.
    Frankel, Arthur E.
    Stein, Anthony
    Sekeres, Mikkael A.
    Swords, Ronan T.
    Medeiros, Bruno C.
    Willekens, Christophe
    Vyas, Paresh
    Tosolini, Alessandra
    Xu, Qiang
    Knight, Robert D.
    Yen, Katharine E.
    Agresta, Sam
    de Botton, Stephane
    Tallman, Martin S.
    BLOOD, 2017, 130 (06) : 722 - 731
  • [7] The role of enasidenib in the treatment of mutant IDH2 acute myeloid leukemia
    Abou Dalle, Iman
    DiNardo, Courtney D.
    THERAPEUTIC ADVANCES IN HEMATOLOGY, 2018, 9 (07) : 163 - 173
  • [8] Enasidenib-induced eosinophilic differentiation in a patient with acute myeloid leukaemia with IDH2 and U2AF1 mutations
    Galeotti, Jonathan
    Coombs, Catherine C.
    BRITISH JOURNAL OF HAEMATOLOGY, 2019, 184 (04) : 496 - 496
  • [9] Targeted therapy with the mutant IDH2 inhibitor enasidenib for high-risk IDH2-mutant myelodysplastic syndrome
    DiNardo, Courtney D.
    Venugopal, Sangeetha
    Lachowiez, Curtis
    Takahashi, Koichi
    Loghavi, Sanam
    Montalban-Bravo, Guillermo
    Wang, Xuemei
    Carraway, Hetty
    Sekeres, Mikkael
    Sukkur, Ameenah
    Hammond, Danielle
    Chien, Kelly
    Maiti, Abhishek
    Masarova, Lucia
    Sasaki, Koji
    Alvarado, Yesid
    Kadia, Tapan
    Short, Nicholas J.
    Daver, Naval
    Borthakur, Gautam
    Ravandi, Farhad
    Kantarjian, Hagop M.
    Patel, Bhumika
    Dezern, Amy
    Roboz, Gail
    Garcia-Manero, Guillermo
    BLOOD ADVANCES, 2023, 7 (11) : 2378 - 2387
  • [10] Thyroiditis: A Rare Manifestation of Enasidenib-Induced Differentiation Syndrome
    Annamaraju, Pavan
    Gopishetty, Swathi
    Goparaju, Naga
    Beasey, Matthew
    Kota, Vamsi
    Guddati, Achuta K.
    CASE REPORTS IN ONCOLOGY, 2020, 13 (02): : 583 - 587
12345